cancerinformation
your most complete directory for cancer information and medications Enter here
kidney disease, cancer symptoms, cancer statistics, colon cancer, colon cancer symptoms, colorectal cancer, kidney cancer, causes of mouth cancer, leukaplakia, emphazima, gastric cancer, endometrial cancer, cancer research, cancer of the liver, cancer of the pancreas, cancer stages, cancer support, cancer information, cancer therapy, cancer vaccines, cancer treatment, cancer treatments, cancer prostate treatment, inflamatory breast cancer, inflammatory breast cancer, esophagus, esophageal cancer, esophagus cancer, cervical cancer early detection, cervical cancer, cervical cancer symptomsIn 1992 in El Paso, TX a randomized, double-blind, cancerinformation placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7
In 1992 in El Paso, TX a randomized, double-blind, cancerinformation placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7
Enter here - your most complete directory for cancer information and medications
cancerinformation
| canceroftheliver | cancerofthepancreas | cancerprostatetreatment | cancerresearch |
| cancerstages | cancerstatistics |
2003 cancer-site.com.
All Rights Reserved. The products mentioned are trademarks of their respective owners and are not owned by us. Read our privacy guidelines.